Clinicians and researchers
Published heat and electrical-stimulation studies that inform SenLore — not FDA results for the finished device.
A Doctor in a Boot.
SenLore™ is designed as a home treatment and remote-monitoring boot for diabetic foot ulcers — patented controlled heat and electrical pulse stimulation built into the same off-loading boot clinicians already prescribe.
Prototype rendering- 4 Granted US Patents
- 9 Peer-Reviewed Papers
- R1 University (UNR DPT)
The problem
Diabetic foot ulcers are more dangerous than most people realize.
0.0 million
People in the U.S. are affected by a diabetic foot ulcer each year.
0%
Of ulcers recur within a year; about 65% recur within five years.
$0 billion
Approximate U.S. treatment spend each year.
A diabetic foot ulcer is often the start of a much larger cascade. In published series, about 80% of diabetes-related amputations are preceded by a foot ulcer, and DFU-related mortality tracks with serious cancers. Recurrence is common — roughly two in five ulcers return within a year, and about two in three within five years — so many people cycle through infection risk, limited walking, and months of clinic-based wound care. That human burden is why U.S. treatment spend is commonly estimated around $11 billion a year. SenLore is being designed for this problem.
How Adlore addresses it
SenLore adds therapy and monitoring to the boot clinicians already use.
Clinicians already prescribe an off-loading boot as part of Diabetic Foot Ulcer care. SenLore keeps that familiar form factor and is designed to add patented electrical stimulation, controlled heat, and sensors for remote monitoring — so treatment can happen at home without a new care pathway.
Prototype renderingThe idea behind SenLore
Published heat + electrical-stimulation studies that inform SenLore — not FDA results for the finished device.
0%
Healing rate at 4 weeks in a published ES + heat series (N=91), vs. about 25% for standard of care.
0%
Average ulcer-area reduction at 4 weeks in a grant-funded ES + heat study, vs. 24% for standard of care.
This research line is documented across and , and underlies .
Hospital and published ES + heat studies; not an FDA-cleared claim about SenLore.
Why now
Prototype, clearance path, and first pilot sites.
SenLore is in active development. It is investigational, not FDA-cleared, and not for sale. Adlore's next steps are a locked prototype, a 510(k) submission package, and first pilot sites with VA and rural partners.
Investment terms and offering details appear with Highlander and Strong Capital Markets.
Follow our progress
Get development updates
A low-commitment way to follow prototype, clearance-path, and news updates. Not an investment, and not a request for health information.
Prototype renderingWho this is for
Clinicians, patients, and investors
Patients and families
What SenLore is designed to do, why it is not for sale yet, and how to follow development.
Investors and press
Company direction and news on this site. Offering details appear only on Highlander and through Strong Capital Markets. Please do not send health information through the contact form.
News & updates
All news
Team · Sep 8, 2026
New DPT program expands physical therapy education in Nevada
University of Nevada, Reno coverage of the Doctor of Physical Therapy program and the John Iliescu, M.D. Physical Therapy Building, featuring director Dr. Daryl Lawson.
Team · Aug 27, 2026
University of Nevada, Reno accepting applications for its inaugural Doctor of Physical Therapy program
KOLO 8 (August 27, 2026) on UNR’s inaugural DPT program, quoting Dr. Daryl Lawson as professor and director.
Press · Jun 10, 2026
Brewing Better Health: Dr. Daryl Lawson on physical therapy and public health
University of Nevada, Reno’s June 10, 2026 Brewing Better Health episode with Dr. Lawson, director of UNR’s Doctor of Physical Therapy program.
Questions we hear often
Is SenLore™ FDA-cleared?
No. SenLore is an investigational device. It is not cleared or approved by the FDA and is not available for sale.
Is this safe?
This website does not claim that SenLore is safe or effective. The device has not been cleared or approved by the FDA. Always consult a qualified clinician about diabetic foot ulcers. Foundational studies of heat and electrical stimulation are not a substitute for evaluation of a commercial SenLore product.
Why isn’t it for sale yet?
SenLore is still in prototype development. Adlore’s next steps are a locked prototype, a 510(k) submission package, and first pilot sites. It is investigational and not for sale.
When can I get one?
There is no commercial availability date on this site. Photos show a prototype in development. Follow News or the progress list for development updates — those are not a waitlist for a cleared product.
Can patients buy or use SenLore today?
Not as a commercial product. The photos on this site show a prototype in development.
What is SenLore designed to do?
It is being developed as a wearable boot that combines controlled heat and electrical pulse stimulation, with sensors intended to support remote monitoring of diabetic foot ulcers. That is a design intent, not a claim that the commercial device has been proven to heal wounds.
How is the boot designed to work?
Heat and electrical stimulation are intended to prompt endothelial cells to release nitric oxide, supporting vasodilation and increased circulation in the foot. Foundational studies of that combination are not the same as clinical results for a finished SenLore product.
Are the statistics on this site results from SenLore?
No. Published numbers come from hospital and published ES + heat studies, including work Dr. Lawson began in his doctoral research. They are comparable to that clinical series — not FDA-cleared claims about a finished SenLore product.
How can I invest?
Adlore is raising through two separate channels. A Regulation Crowdfunding offering, when open, is available only on Highlander. Accredited investors can discuss a separate Regulation D placement with Strong Capital Markets. Terms for either offering are not published in story copy on this site.
What happens to my money if I invest?
Investment terms, eligibility, and how funds are handled appear only in the official offering materials — on Highlander for Regulation Crowdfunding, or through Strong Capital Markets for the Regulation D placement. This website is not an offer to sell securities and does not publish raise amounts or use of proceeds.
SenLore™ is an investigational device, not yet available for sale or cleared by the FDA.